HHC
DPLO

Hutchin Hill Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Hutchin Hill Capital’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-105,100
Closed -$1.55M – 1069
2017
Q2 		$1.55M Buy
+105,100
New +$1.75M 0.05% 397

Other funds holding DPLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hutchin Hill Capital's DPLO Position: Q3 2017 in Review

Hutchin Hill Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2017, closing a stake of 105,100 shares — an estimated $1.55M sold.

Hutchin Hill Capital first reported a position in DPLO in Q2 2017 and held it in 1 quarter. The position peaked at $1.55M in Q2 2017. 165 funds tracked by Wall St. Rank hold DPLO as of Q3 2017.

  • Hutchin Hill Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 105,100 DIPLOMAT PHARMACY, INC. shares in Q3 2017, an estimated $1.55M.
  • Hutchin Hill Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2017 and held it in 1 quarter.
  • Hutchin Hill Capital's DIPLOMAT PHARMACY, INC. position peaked at $1.55M in Q2 2017.
  • 165 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.